Passage BIO PASG
NASDAQ PASG
$4.32 -0.18 (-4.11%)
As of: Oct 1, 2026 · 3:59 PM EDT

Passage BIO (PASG) Other Non-Current Liabilities (2019 - 2023)

Updated

Passage BIO's Other Non-Current Liabilities was $2 million in Q1 2023.

Analysis

Passage BIO (PASG) Other Non-Current Liabilities (2019 - 2023) Analysis & Trends

At the end of FY2021, Other Non-Current Liabilities at Passage BIO came in at $6.92 million, up 233.2% from FY2020.

  • In earlier years, Other Non-Current Liabilities was $2.08 million in FY2020 (+312.1%) and $504,000 in FY2019.
  • The Q1 2023 figure marks the highest quarterly Other Non-Current Liabilities since Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Passage BIO 14.48 Mn 14.48 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 2.00 Mn
Dec 31, 2021 6.92 Mn
Sep 30, 2021 6.46 Mn
Jun 30, 2021 6.01 Mn
Mar 31, 2021 4.20 Mn
Dec 31, 2020 2.08 Mn
Sep 30, 2020 643,000.00
Jun 30, 2020 524,000.00
Mar 31, 2020 489,000.00
Dec 31, 2019 504,000.00
API Access

Passage BIO Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PASG&period=max&api_key=YOUR_API_KEY